SD | Shutterstock
Instead of targeting hunger, the experimental drug activates metabolism inside skeletal muscle. Researchers say this approach improved blood sugar regulation and body composition in animal studies while avoiding several side effects often linked to GLP-1 therapies, including appetite suppression, muscle loss, and digestive issues. The treatment is taken as a tablet rather than an injection.